Ashish Dhawan exited his biggest stock bet in Q2


NEW DELHI: Seasoned investor Ashish Dhawan has sold his entire stake in Max Healthcare, shareholding pattern suggests. The ace investor also booked profits in Birlasoft and Zensar Technologies, two other high-flying stocks during the quarter.

Dhawan, whose stock portfolio is worth Rs 2,000 crore, offloaded Max Healthcare shares after owning them for five quarters.

At 1.42 per cent in June quarter, Dhawan’s stake in Max Healthcare was valued roughly at over Rs 450 crore, making it his biggest holding.

The scrip had rallied 260 per cent from October 2020 levels to the middle of September, before losing ground. At Rs 338 a piece on Wednesday, the scrip is off 40 per cent from its September 16 high of Rs 472.60. had earlier reported that the stock was looking exhausted on technical charts. Dhawan himself had trimmed his stake in Max Healthcare to 1.42 per cent in the June quarter from 1.67 per cent in the March quarter.

Dhawan was also seen booking profits on Birlasoft in September quarter as he cut his stake in this firm to 1.8 per cent from 2.88 per cent sequentially. This was the lowest ever stake Dhawan has held in the IT company since he entered the counter in December 2019. This stock was up 650 per cent in the last one year.

Dhawan made no changes to three other portfolio stocks while trimming stake in ZEN Technologies.

In Max India his stake remained unchanged sequentially at 6.1 per cent. He held on to his 1.1 per cent stake in Quess Corp. He also did not tinker with RPSG Ventures. In Zensar Technologies, he trimmed stake to 1.1 per cent from 1.2 per cent. This stock had rallied 157 per cent in the last one year.

Dhawan’s wealth jumped five fold from Rs 521 crore in March quarter of 2020 to Rs 2,544 crore at the end of September quarter, data publicly available with Trendlyne suggested. That portfolio value has fallen of late to Rs 2,000 crore odd levels.





This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More